-

Piper Sandler Expands European Healthcare Investment Banking with the Hiring of Vincenzo di Nicola

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Vincenzo di Nicola as a managing director within the firm’s healthcare investment banking group. He will expand the firm’s European healthcare team and the global pharma outsourcing coverage, and will be based in the firm’s London office.

Prior to joining the firm, di Nicola was a managing director, head of healthcare Europe and co-head of pharma outsourcing at Cantor Fitzgerald. Prior to that, he was a managing director and head of healthcare Europe at Robert W. Baird & Co.

“We are excited to welcome Vincenzo to our healthcare platform,” said Peter Day, co-head of healthcare investment banking at Piper Sandler. “With 20 years of investment banking experience predominantly focused on healthcare, we look forward to leveraging Vincenzo’s deep industry expertise as we expand our European healthcare investment banking platform as well as strengthen our global pharma outsourcing coverage.”

Di Nicola earned a bachelor’s degree in international economics from the University of Naples and a Masters in Finance from the London Business School.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in Europe through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Private equity strategies and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | Twitter

©2021. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Summary
Piper Sandler Expands European Healthcare Investment Banking with the Hiring of Vincenzo di Nicola

Contacts

Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com

More News From Piper Sandler Companies

Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distr...

Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share

MINNEAPOLIS--(BUSINESS WIRE)--The complete earnings release can be found on the firm's website at pipersandler.com/earnings...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormack

MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in the healthcare investment banking group. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions. “We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising bioph...
Back to Newsroom